Kyzatrex® (Oral Testosterone)
An oral testosterone option that may help support energy, strength, and body composition.
- Energy, strength and body composition, where hypogonadism is confirmed
- An FDA-approved, as-manufactured product rather than a compounded preparation
- An oral route with no needles and no risk of transferring to others
For men with hypogonadism confirmed on symptoms and labs. FDA labeling carries a Limitation of Use: safety and efficacy have not been established for low testosterone due to aging alone.
Pricing confirmed after eligibility · prescription treatment
What Kyzatrex is and how it works
For most of the history of testosterone therapy, oral testosterone was a problem to be avoided. Early oral formulations were metabolized heavily by the liver and carried hepatic risks serious enough that injections, gels and pellets became the standard despite being less convenient.
Kyzatrex® is part of a newer generation that solved that problem differently — and it's why an oral route is a genuine option again rather than a compromise. If needles have been the reason you've put off treatment, this is the conversation worth having.
Kyzatrex® is an FDA-approved oral testosterone undecanoate. It is a manufactured, branded medication dispensed as made — not a compounded preparation. The formulation works by taking a different route into the body: rather than being absorbed into the portal circulation and passing straight through the liver, testosterone undecanoate is absorbed largely via the intestinal lymphatic system, which bypasses that first-pass hepatic metabolism. That is the design difference that made modern oral testosterone viable — and it has one practical consequence you need to know about, covered below.
How it works here
Every plan follows one path. Each step feeds the next. See the Men's Testosterone Therapy approach.
- 01
Measure
We baseline your labs, history, and goals.
- 02
Plan
A clinician decides whether this fits — and what else might serve you.
- 03
Act
If appropriate, you start with clear guidance and high-touch support.
- 04
Track
We monitor how you respond on a defined cadence.
- 05
Adjust
Protocols are refined over time. Guided care, not a kit in the mail.
Why it must be taken with food
This isn't a preference or a comfort measure — it is how the medication works.
Lymphatic absorption depends on dietary fat. Taken on an empty stomach, absorption drops substantially and blood levels can end up well below what is intended. Someone who takes it without food and concludes “oral testosterone doesn't work for me” may simply not have absorbed it.
So the meal matters as much as the medication. Your clinician will cover the specifics, but if you're the sort of person who skips breakfast, that is worth raising during your consultation rather than discovering later through a disappointing lab result.
Oral, injection, cream or pellet?
There's no universally superior route — there's the one that fits your labs, your preferences, and what you'll actually stay consistent with.
| Oral (Kyzatrex®) | Injection | Cream / Gel | Pellet | |
|---|---|---|---|---|
| Needles | No | Yes | No | Implant procedure |
| Must be taken with food | Yes — absorption depends on it | No | No | No |
| Risk of transferring to others | None | None | Yes — skin contact with partners or children | None |
| Blood level pattern | Steadier across the day | Peaks and troughs between doses | Relatively steady | Steady, then tapering |
| Regulatory status | FDA-approved | FDA-approved | FDA-approved | FDA-approved |
| Relative cost | Highest — branded | Lowest | Middle | Middle to high |
| If you want to stop | Straightforward | Straightforward | Straightforward | Must wait for the implant to exhaust |
| Main practical drawback | Requires eating with it, reliably | Needles and self-administration | Transference precautions and application routine | Minor procedure; not easily reversed |
| Best suited to | Men who won't stick with needles and eat regular meals | Men where cost is the deciding factor | Men who prefer topical and have no small children at home | Men who want to think about it as little as possible |
Scroll the table sideways to compare →
Two rows do most of the deciding in practice. Transference rules out cream for men with young children or a partner who'd be exposed. And taking it with food rules out oral for men who genuinely skip meals — not as an inconvenience, but because absorption fails without it.
The best route is ultimately the one you don't abandon. Men's testosterone therapy covers the comparison in more depth.
What to watch for
Testosterone therapy of any route has a known profile, which is one of its advantages — the things to watch are established rather than speculative.
Blood pressure increases — a class-wide effect, monitored throughout.
Polycythemia — a rise in red blood cell concentration, tracked via hematocrit, and one of the more common reasons a protocol gets adjusted.
Effects on sperm production — testosterone replacement of any kind suppresses fertility. If that matters to you, say so before starting; enclomiphene exists partly for this reason.
Prostate considerations — including worsening of benign prostatic hyperplasia, which is why prostate assessment is part of baseline and follow-up.
Sleep apnea, which can worsen, along with lipid changes, edema and gynecomastia.
Mood changes, which are worth flagging early.
None of these are reasons to avoid treatment when it is indicated. They are the reasons monitoring isn't optional.
Who this isn't right for
Testosterone therapy isn't appropriate for men with prostate or breast cancer, for men whose partners are pregnant or who are trying to conceive, or for men with untreated severe sleep apnea or significant uncontrolled cardiovascular disease. A history of blood clots warrants careful discussion.
And it isn't appropriate for men who simply want higher testosterone without a diagnosis. That is the Limitation of Use point, and it is where a clinician-led program differs from a subscription.
What monitoring looks like
A baseline before starting: total and free testosterone, estradiol, SHBG, LH and FSH, a complete blood count with hematocrit, lipids, PSA and prostate assessment, blood pressure, and a full medication history.
Then follow-up on a defined cadence — checking that levels are where they should be, that hematocrit and blood pressure haven't drifted, that PSA is stable, and that how you feel has actually changed. Timing of labs relative to dosing matters for interpretation, which your clinician will direct.
Delivery
An oral capsule, taken with food, with the regimen guided by your clinician and adjusted from your labs.
Is it right for you?
Kyzatrex® fits men in midlife with confirmed hypogonadism who prefer an oral route, who can reliably take a medication with food, and who want an FDA-approved product rather than a compounded one. If preserving fertility is a priority, enclomiphene is the more appropriate first conversation, since testosterone replacement suppresses sperm production. If cost is the deciding factor, injectable testosterone is generally less expensive. And if low libido or sexual function is the main concern, sexual wellness is worth reading alongside this, since testosterone is one input among several.
Often considered alongside
Enclomiphene / DHEA / Boron / Pregnenolone ODT
CompoundedA dissolving tablet combining enclomiphene, DHEA, boron, and pregnenolone to support the body's own testosterone production.
View treatmentTestosterone Replacement Therapy (TRT)
A monitored testosterone program built from your labs, with dosing and delivery chosen with your clinician.
View treatmentProducts marked Compounded are prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved and are not equivalent to or interchangeable with any branded product.
An honest word on the evidence — including what the label says about age
Testosterone therapy is well established for men with diagnosed hypogonadism. For eligible patients under proper monitoring it is one of the better-supported treatments in men's health, and Kyzatrex® has been through FDA review — which is more than can be said for many products in this space. Two things are worth stating plainly that most sites selling testosterone leave out. First, the label carries a Limitation of Use for age-related hypogonadism: FDA retains language stating that the safety and efficacy of testosterone products have not been established for low testosterone due to aging alone. Our patients are, by definition, in midlife. That does not mean treatment is inappropriate — it means the diagnosis matters. Treatment is for men with hypogonadism confirmed on labs and symptoms, not for men whose testosterone is simply lower than it was at 25, and distinguishing those two is much of what your baseline is for. Second, the cardiovascular picture changed recently, in testosterone's favor. In February 2025 the FDA announced class-wide labeling changes for testosterone products following the TRAVERSE trial, which found no increase in adverse cardiovascular outcomes in men treated for hypogonadism, and the boxed warning language about cardiovascular risk was removed. At the same time, FDA's ambulatory blood pressure studies confirmed a class-wide increase in blood pressure, so blood pressure moved into the warnings section as a monitored effect rather than a boxed warning. The short version: the heart-attack scare that shaped a decade of testosterone coverage was not borne out, but blood pressure is a real and monitorable effect. If you read something alarming about testosterone and cardiovascular risk, check its date.
References
Government and professional-society sources consulted for this page.
- Testosterone Injection — MedlinePlus (U.S. National Library of Medicine)
- Prostate-Specific Antigen (PSA) Test Fact Sheet — National Cancer Institute
Frequently asked questions
For eligible patients under monitoring, it's a well-established treatment. Modern oral testosterone undecanoate avoids the liver toxicity associated with older oral formulations by using lymphatic absorption. Safety comes from oversight: regular labs, blood pressure checks and adjustment over time.
Not as of the current label. FDA announced class-wide testosterone labeling changes in February 2025 following the TRAVERSE trial, which found no increase in adverse cardiovascular outcomes in men treated for hypogonadism, and the boxed warning language on cardiovascular risk was removed. Blood pressure increases are now addressed in the warnings and precautions section. Older articles online may still describe the previous label.
Because absorption depends on it. Kyzatrex is absorbed largely through the intestinal lymphatic system, and that route requires dietary fat. Taken on an empty stomach, levels can end up substantially lower than intended.
It's an oral route with no needles and a different pattern of levels over time. Injections are typically less expensive. A clinician helps determine which fits your goals, labs and what you'll realistically stay consistent with.
Yes. Testosterone replacement of any route suppresses the signaling that drives sperm production. If fertility matters to you now or later, raise it before starting — enclomiphene supports your own production instead and generally preserves fertility.
Your protocol is reviewed and adjusted over time, decided together based on your data. Stopping is a legitimate outcome, though it's worth understanding in advance that your own production will have been suppressed while on therapy and takes time to recover.
FDA's ambulatory blood pressure studies confirmed an increase across all testosterone products as a class effect. It's monitored throughout treatment, and for most eligible men it's manageable — but it's a real effect rather than a theoretical one.
FDA labeling states that safety and efficacy have not been established for low testosterone due solely to aging. In practice this means treatment is appropriate for men with hypogonadism confirmed by symptoms and labs, not for men whose levels are simply lower than in their twenties. Establishing which applies to you is what the baseline is for.
Both are oral testosterone undecanoate products with broadly similar mechanisms and different formulation details. Which is available and appropriate depends on your clinical picture and what your pharmacy can supply.
See if Kyzatrex® (Oral Testosterone) fits your plan
The right plan begins with knowing where you are. Start with a short eligibility check and a baseline — and we'll tell you, honestly, what fits.
We measure first. Then we act.
ACT 2 Health provides clinician-led care. Treatments described are available only to eligible patients following clinical evaluation and within applicable regulations. This page is educational and is not medical advice. Individual results vary.